8-K Announcements
6Material company update
Apr 29, 2026·SEC
Material company update
Feb 18, 2026·SEC
Material company update
Jan 2, 2026·SEC
Bausch + Lomb Corporation(BLCO)Earnings, Financials & Key Ratios
BLCO•NYSE
Price updated Jun 19, 2026
AboutBausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.Show more
- Revenue$5.1B+6.5%
- EBITDA$609M+1.8%
- Net Income-$360M-13.6%
- EPS (Diluted)-1.02-13.3%
- Gross Margin54.75%-10.1%
- EBITDA Margin11.94%-4.3%
- Operating Margin3.69%+9.0%
- Net Margin-7.06%-6.7%
- ROE-5.51%-17.1%
BLCO Key Insights
Bausch + Lomb Corporation (BLCO) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Trading at only 0.8x book value
✗Weaknesses
- ✗Profits declining 82.1% over 5 years
- ✗Weak Piotroski F-Score: 3/9
- ✗Negative free cash flow
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when BLCO posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
BLCO Price & Volume
Bausch + Lomb Corporation (BLCO) stock price & volume — 10-year historical chart
Loading chart...
BLCO Growth Metrics
Bausch + Lomb Corporation (BLCO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years8.38%
3 Years10.62%
TTM7.85%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM39.5%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM39.74%
Return on Capital
10 Years2.26%
5 Years1.91%
3 Years1.38%
Last Year1.58%
BLCO Recent Earnings
Bausch + Lomb Corporation (BLCO) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 5/12 qtrs (42%)
Q2 2026Latest
Apr 29, 2026Metric
Actual
Est
EPS
$0.08+33.3%
$0.06
Rev
$1.2B+2.3%
$1.2B
Q1 2026
Feb 18, 2026Metric
Actual
Est
EPS
$0.32-8.6%
$0.35
Rev
$1.4B+1.4%
$1.4B
Q4 2025
Oct 29, 2025Metric
Actual
Est
EPS
$0.18+12.5%
$0.16
Rev
$1.3B-7.4%
$1.4B
Q3 2025
Jul 30, 2025Metric
Actual
Est
EPS
$0.07+16.7%
$0.06
Rev
$1.3B+0.3%
$1.3B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 29, 2026 | $0.08vs $0.06+33.3% | $1.2Bvs $1.2B+2.3% |
| Q1 2026 | Feb 18, 2026 | $0.32vs $0.35-8.6% | $1.4Bvs $1.4B+1.4% |
| Q4 2025 | Oct 29, 2025 | $0.18vs $0.16+12.5% | $1.3Bvs $1.4B-7.4% |
| Q3 2025 | Jul 30, 2025 | $0.07vs $0.06+16.7% | $1.3Bvs $1.3B+0.3% |
Based on last 12 quarters of dataView full earnings history →
BLCO Peer Comparison
Bausch + Lomb Corporation (BLCO) competitors in Dental and vision care devices — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 HSIC | 9.17B | 79.92 | 24.44 | 4.03% | 3.02% | 8.24% | 0.77 | |
 ATRC | 1.46B | 28.80 | -120 | 14.88% | -0.83% | -0.95% | 0.18 | |
 LNTH | 6.76B | 103.86 | 30.46 | 0.5% | 18.05% | 24.33% | 0.00 | |
 JNJ | 550.4B | 228.39 | 39.45 | 4.3% | 27.26% | 31.69% | 0.51 | |
 ABT | 153.68B | 88.38 | 11.57 | 4.59% | 31.88% | 27.26% | 0.32 | |
 COO | 12.85B | 65.91 | 35.25 | 5.06% | 5.57% | 2.84% | 0.34 | |
 HOLX | 16.97B | 76.01 | 30.53 | 1.74% | 13.18% | 11.01% | 0.52 | |
 IART | 1.37B | 17.58 | -2.61 | 1.53% | -30.15% | -47.65% | 1.95 |
Compare BLCO vs Peers
Bausch + Lomb Corporation (BLCO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
BLCO Income Statement
Bausch + Lomb Corporation (BLCO) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 3.78B | 3.41B | 3.77B | 3.77B | 4.15B | 4.79B | 5.1B | 5.21B |
Revenue Growth % | - | -9.69% | 10.35% | 0.08% | 10.03% | 15.56% | 6.47% | 7.85% |
Cost of Goods Sold | 1.33B | 1.28B | 1.47B | 1.52B | 1.64B | 1.87B | 2.31B | 2.3B |
COGS % of Revenue | 35.12% | 37.66% | 38.96% | 40.31% | 39.6% | 39.07% | 45.25% | - |
Gross Profit | 2.45B▲ 0% | 2.13B▼ 13.2% | 2.3B▲ 8.0% | 2.25B▼ 2.1% | 2.5B▲ 11.3% | 2.92B▲ 16.6% | 2.79B▼ 4.3% | 2.91B▲ 0% |
Gross Margin % | 64.88% | 62.34% | 61.04% | 59.69% | 60.4% | 60.93% | 54.75% | 55.86% |
Gross Profit Growth % | - | -13.22% | 8.04% | -2.13% | 11.34% | 16.57% | -4.32% | - |
Operating Expenses | 2.06B | 1.87B | 1.97B | 2.04B | 2.37B | 2.76B | 2.6B | 2.6B |
OpEx % of Revenue | 54.39% | 54.72% | 52.3% | 54.19% | 57.26% | 57.55% | 51.07% | - |
Selling, General & Admin | 1.38B | 1.25B | 1.39B | 1.48B | 1.74B | 2.08B | 2.23B | 2.21B |
SG&A % of Revenue | 36.58% | 36.72% | 36.89% | 39.23% | 41.87% | 43.46% | 43.8% | - |
Research & Development | 258M | 281M | 271M | 307M | 324M | 343M | 371M | 386M |
R&D % of Revenue | 6.83% | 8.24% | 7.2% | 8.15% | 7.81% | 7.16% | 7.27% | - |
Other Operating Expenses | 415M | 333M | 309M | 257M | 314M | 332M | 0 | 0 |
Operating Income | 396M▲ 0% | 260M▼ 34.3% | 329M▲ 26.5% | 207M▼ 37.1% | 130M▼ 37.2% | 162M▲ 24.6% | 188M▲ 16.0% | 308M▲ 0% |
Operating Margin % | 10.48% | 7.62% | 8.74% | 5.49% | 3.14% | 3.38% | 3.69% | 5.91% |
Operating Income Growth % | - | -34.34% | 26.54% | -37.08% | -37.2% | 24.62% | 16.05% | - |
EBITDA | 865M | 702M | 744M | 586M | 512M | 598M | 609M | 724M |
EBITDA Margin % | 22.9% | 20.57% | 19.76% | 15.55% | 12.35% | 12.48% | 11.94% | 13.9% |
EBITDA Growth % | - | -18.84% | 5.98% | -21.24% | -12.63% | 16.8% | 1.84% | 37.38% |
D&A (Non-Cash Add-back) | 469M | 442M | 415M | 379M | 382M | 436M | 421M | 416M |
EBIT | 467M | 290M | 318M | 219M | 117M | 165M | 188M | 308M |
Net Interest Income | 1M | 3M | 0 | -140M | -268M | -384M | -419M | -421M |
Interest Income | 1M | 3M | 0 | 6M | 15M | 15M | 12M | 13M |
Interest Expense | 0 | 0 | 0 | 146M | 283M | 399M | 431M | 434M |
Other Income/Expense | 3M | 30M | -11M | -134M | -296M | -396M | -505M | -509M |
Pretax Income | 399M▲ 0% | 290M▼ 27.3% | 318M▲ 9.7% | 73M▼ 77.0% | -166M▼ 327.4% | -234M▼ 41.0% | -317M▼ 35.5% | -201M▲ 0% |
Pretax Margin % | 10.56% | 8.5% | 8.45% | 1.94% | -4% | -4.88% | -6.21% | -3.86% |
Income Tax | 96M | 307M | 125M | 58M | 82M | 71M | 35M | 10M |
Effective Tax Rate % | 24.06% | 105.86% | 39.31% | 79.45% | -49.4% | -30.34% | -11.04% | -4.98% |
Net Income | 298M▲ 0% | -18M▼ 106.0% | 182M▲ 1111.1% | 6M▼ 96.7% | -260M▼ 4433.3% | -317M▼ 21.9% | -360M▼ 13.6% | -219M▲ 0% |
Net Margin % | 7.89% | -0.53% | 4.83% | 0.16% | -6.27% | -6.62% | -7.06% | -4.21% |
Net Income Growth % | - | -106.04% | 1111.11% | -96.7% | -4433.33% | -21.92% | -13.56% | 39.5% |
Net Income (Continuing) | 303M | -17M | 193M | 15M | -248M | -305M | -352M | -211M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 73M | 70M | 73M | 68M | 70M | 71M | 71M | 73M |
EPS (Diluted) | 0.85▲ 0% | -0.05▼ 105.7% | 0.52▲ 1170.0% | 0.04▼ 91.8% | -0.74▼ 1824.9% | -0.90▼ 21.6% | -1.02▼ 13.3% | -0.62▲ 0% |
EPS Growth % | - | -105.72% | 1169.96% | -91.75% | -1824.94% | -21.62% | -13.33% | 39.74% |
EPS (Basic) | 0.85 | -0.05 | 0.52 | 0.04 | -0.74 | -0.90 | -1.02 | - |
Diluted Shares Outstanding | 350M | 350M | 350M | 350M | 350.5M | 351.8M | 353.8M | 355.2M |
Basic Shares Outstanding | 350M | 350M | 350M | 350M | 350.5M | 351.8M | 353.8M | 355.2M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - |
BLCO Balance Sheet
Bausch + Lomb Corporation (BLCO) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Total Current Assets | 1.7B | 1.65B | 1.64B | 2.14B | 2.74B | 2.79B | 2.98B | 2.78B |
Cash & Short-Term Investments | 192M | 238M | 174M | 380M | 334M | 305M | 383M | 268M |
Cash Only | 192M | 238M | 174M | 380M | 334M | 305M | 383M | 268M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 713M | 645M | 721M | 726M | 875M | 1.03B | 1.22B | 1.11B |
Days Sales Outstanding | 68.88 | 69 | 69.9 | 70.33 | 77.03 | 78.17 | 87.37 | 79 |
Inventory | 592M | 616M | 572M | 628M | 1.03B | 1.04B | 976M | 977M |
Days Inventory Outstanding | 162.83 | 174.97 | 142.32 | 150.9 | 228.51 | 202 | 154.35 | 159.12 |
Other Current Assets | 198M | 155M | 3M | 403M | 505M | 421M | 397M | 425M |
Total Non-Current Assets | 9.77B | 9.61B | 9.19B | 9.01B | 10.7B | 10.68B | 11.04B | 11B |
Property, Plant & Equipment | 1.09B | 1.26B | 1.34B | 1.42B | 1.5B | 1.49B | 1.76B | 1.79B |
Fixed Asset Turnover | 3.47x | 2.70x | 2.82x | 2.66x | 2.76x | 3.23x | 2.90x | 3.00x |
Goodwill | 4.55B | 4.68B | 4.59B | 4.51B | 4.58B | 4.52B | 4.76B | 4.74B |
Intangible Assets | 2.85B | 2.56B | 2.26B | 2.06B | 3.59B | 3.49B | 3.28B | 3.23B |
Long-Term Investments | 0 | 0 | 0 | 12M | 19M | 19M | 7M | 14M |
Other Non-Current Assets | 82M | 65M | 1B | 84M | 92M | 275M | 303M | 302M |
Total Assets | 11.47B▲ 0% | 11.27B▼ 1.8% | 10.82B▼ 3.9% | 11.14B▲ 3.0% | 13.44B▲ 20.6% | 13.47B▲ 0.2% | 14.02B▲ 4.1% | 13.78B▲ 0% |
Asset Turnover | 0.33x | 0.30x | 0.35x | 0.34x | 0.31x | 0.36x | 0.36x | 0.38x |
Asset Growth % | - | -1.76% | -3.93% | 2.97% | 20.62% | 0.2% | 4.11% | 13.47% |
Total Current Liabilities | 1.03B | 909M | 1.1B | 1.3B | 1.58B | 1.74B | 1.92B | 1.82B |
Accounts Payable | 262M | 178M | 239M | 317M | 522M | 389M | 388M | 407M |
Days Payables Outstanding | 72.06 | 50.56 | 59.46 | 76.17 | 116.04 | 75.85 | 61.36 | 65.05 |
Short-Term Debt | 16M | 18M | 28M | 51M | 57M | 40M | 77M | 39M |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 573M | 544M | 356M | 732M | 709M | 1.28B | 1.46B | 1.37B |
Current Ratio | 1.64x | 1.82x | 1.49x | 1.65x | 1.74x | 1.60x | 1.55x | 1.53x |
Quick Ratio | 1.07x | 1.14x | 0.97x | 1.16x | 1.09x | 1.01x | 1.04x | 0.99x |
Cash Conversion Cycle | 159.65 | 193.41 | 152.75 | 145.06 | 189.51 | 204.32 | 180.36 | 173.07 |
Total Non-Current Liabilities | 401M | 369M | 322M | 2.75B | 4.94B | 5.19B | 5.58B | 5.51B |
Long-Term Debt | 0 | 0 | 0 | 2.41B | 4.53B | 4.74B | 5.17B | 0 |
Capital Lease Obligations | 77M | 83M | 92M | 92M | 87M | 120M | 125M | 125M |
Deferred Tax Liabilities | 0 | 0 | 0 | 7M | 14M | 13M | 19M | 66M |
Other Non-Current Liabilities | 324M | 286M | 230M | 237M | 310M | 310M | 271M | 5.49B |
Total Liabilities | 1.44B | 1.28B | 1.42B | 4.04B | 6.52B | 6.92B | 7.5B | 7.33B |
Total Debt | 93M | 101M | 140M | 2.55B | 4.68B | 4.94B | 5.37B | 39M |
Net Debt | -99M | -137M | -34M | 2.17B | 4.34B | 4.63B | 4.99B | -229M |
Debt / Equity | 0.01x | 0.01x | 0.01x | 0.36x | 0.68x | 0.75x | 0.82x | 0.01x |
Debt / EBITDA | 0.11x | 0.14x | 0.19x | 4.36x | 9.13x | 8.25x | 8.82x | 0.05x |
Net Debt / EBITDA | -0.11x | -0.20x | -0.05x | 3.71x | 8.48x | 7.74x | 8.19x | -0.32x |
Interest Coverage | - | - | - | 1.50x | 0.41x | 0.41x | 0.44x | 0.71x |
Total Equity | 10.03B▲ 0% | 9.99B▼ 0.4% | 9.4B▼ 5.9% | 7.1B▼ 24.5% | 6.92B▼ 2.5% | 6.54B▼ 5.4% | 6.52B▼ 0.4% | 6.45B▲ 0% |
Equity Growth % | - | -0.44% | -5.87% | -24.47% | -2.55% | -5.43% | -0.38% | -3.6% |
Book Value per Share | 28.66 | 28.54 | 26.86 | 20.29 | 19.74 | 18.60 | 18.43 | 18.16 |
Total Shareholders' Equity | 9.96B | 9.92B | 9.33B | 7.03B | 6.85B | 6.47B | 6.45B | 6.38B |
Common Stock | 11.01B | 10.81B | 10.36B | 0 | 0 | 0 | 0 | 0 |
Retained Earnings | 0 | 0 | 0 | 6M | -254M | -571M | -931M | -1B |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -1.05B | -889M | -1.03B | -1.26B | -1.25B | -1.39B | -1.18B | -1.2B |
Minority Interest | 73M | 70M | 73M | 68M | 70M | 71M | 71M | 73M |
BLCO Cash Flow Statement
Bausch + Lomb Corporation (BLCO) cash flow — operating, investing & free cash flow history
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Cash from Operations | 799M | 522M | 873M | 345M | -17M | 232M | 283M | 340.39M |
Operating CF Margin % | 21.15% | 15.3% | 23.19% | 9.16% | -0.41% | 4.84% | 5.55% | - |
Operating CF Growth % | - | -34.67% | 67.24% | -60.48% | -104.93% | 1464.71% | 21.98% | 862.25% |
Net Income | 303M | -17M | 193M | 15M | -248M | -305M | -352M | -219M |
Depreciation & Amortization | 469M | 442M | 415M | 379M | 382M | 436M | 421M | 416M |
Stock-Based Compensation | 50M | 50M | 62M | 62M | 74M | 92M | 149M | 64M |
Deferred Taxes | -39M | 97M | 116M | -90M | -10M | -10M | -32M | -60.39M |
Other Non-Cash Items | 56M | 9M | 59M | -2M | 72M | 106M | 79M | 164.63M |
Working Capital Changes | -40M | -59M | 28M | -19M | -287M | -87M | 18M | -28.85M |
Change in Receivables | -21M | 77M | -107M | -95M | -121M | -227M | -148M | -86.24M |
Change in Inventory | -91M | -32M | -15M | -106M | -264M | -147M | 38M | 28.26M |
Change in Payables | 78M | -144M | 163M | 189M | 245M | 126M | 108M | 35.86M |
Cash from Investing | -186M | -256M | -214M | -215M | -2.11B | -412M | -455M | -466.16M |
Capital Expenditures | -180M | -259M | -193M | -175M | -181M | -291M | -349M | -336.06M |
CapEx % of Revenue | 4.76% | 7.59% | 5.13% | 4.64% | 4.37% | 6.07% | 6.84% | 6.45% |
Acquisitions | 6M | 6M | -16M | 45M | -1.94B | 0 | 0 | 7.01M |
Investments | - | - | - | - | - | - | - | - |
Other Investing | -6M | -6M | 0 | -45M | 14M | -123M | -103M | -25.09M |
Cash from Financing | -606M | -232M | -712M | 81M | 2.08B | 178M | 225M | 172.25M |
Debt Issued (Net) | 0 | 0 | 28M | 2.46B | 2.12B | 201M | 249M | 203.75M |
Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | -12M | 0 | 0 |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | -12M | 0 | -2M |
Other Financing | -606M | -232M | -740M | -2.38B | -37M | -11M | -24M | -31.5M |
Net Change in Cash | 4M▲ 0% | 46M▲ 1050.0% | -61M▼ 232.6% | 203M▲ 432.8% | -46M▼ 122.7% | -18M▲ 60.9% | 81M▲ 550.0% | 64M▲ 0% |
Free Cash Flow | 619M▲ 0% | 263M▼ 57.5% | 680M▲ 158.6% | 170M▼ 75.0% | -198M▼ 216.5% | -59M▲ 70.2% | -66M▼ 11.9% | 4.33M▲ 0% |
FCF Margin % | 16.38% | 7.71% | 18.06% | 4.51% | -4.78% | -1.23% | -1.29% | 0.08% |
FCF Growth % | - | -57.51% | 158.56% | -75% | -216.47% | 70.2% | -11.86% | 102.58% |
FCF per Share | 1.77 | 0.75 | 1.94 | 0.49 | -0.56 | -0.17 | -0.19 | 0.01 |
FCF Conversion (FCF/Net Income) | 2.68x | -29.00x | 4.80x | 57.50x | 0.07x | -0.73x | -0.79x | -0.02x |
Interest Paid | 0 | 3M | 0 | 132M | 238M | 415M | 0 | 0 |
Taxes Paid | 0 | 57M | 53M | 83M | 64M | 91M | 0 | 0 |
BLCO Key Ratios
Bausch + Lomb Corporation (BLCO) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -0.18% | 1.88% | 0.07% | -3.71% | -4.71% | -5.51% | -3.37% |
Return on Invested Capital (ROIC) | 1.97% | 2.57% | 1.67% | 0.95% | 1.08% | 1.24% | 2.31% |
Gross Margin | 62.34% | 61.04% | 59.69% | 60.4% | 60.93% | 54.75% | 55.86% |
Net Margin | -0.53% | 4.83% | 0.16% | -6.27% | -6.62% | -7.06% | -4.21% |
Debt / Equity | 0.01x | 0.01x | 0.36x | 0.68x | 0.75x | 0.82x | 0.01x |
Interest Coverage | - | - | 1.50x | 0.41x | 0.41x | 0.44x | 0.71x |
FCF Conversion | -29.00x | 4.80x | 57.50x | 0.07x | -0.73x | -0.79x | -0.02x |
Revenue Growth | -9.69% | 10.35% | 0.08% | 10.03% | 15.56% | 6.47% | 7.85% |
Related:BLCO Dividend History·BLCO Revenue History·BLCO Price History·BLCO P/E History·BLCO Financial Ratios·BLCO Institutional Holders
BLCO SEC Filings & Documents
Bausch + Lomb Corporation (BLCO) SEC filings — annual & quarterly reports (10-K, 10-Q)
BLCO Frequently Asked Questions
Bausch + Lomb Corporation (BLCO) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Bausch + Lomb Corporation (BLCO) reported $5.21B in revenue for fiscal year 2025. This represents a 38% increase from $3.78B in 2019.
Bausch + Lomb Corporation (BLCO) grew revenue by 6.5% over the past year. This is steady growth.
Bausch + Lomb Corporation (BLCO) reported a net loss of $219.0M for fiscal year 2025.
Dividend & Returns
Bausch + Lomb Corporation (BLCO) has a return on equity (ROE) of -5.5%. Negative ROE indicates the company is unprofitable.
Bausch + Lomb Corporation (BLCO) generated $4.3M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.